THE WHO DEPRESSION SCALEBECH P; GRAM LF; REISBY N et al.1980; ACTA PSYCHIATR. SCAND.; ISSN 0001-690X; DNK; DA. 1980; VOL. 62; NO 2; PP. 140-153; BIBL. 2 P.Article

RELEVANCE OF TRYPTOPHAN AND TYROSINE AVAILABILITY IN ENDOGENOUS AND "NON-ENDOGENOUS" DEPRESSIVES TREATED WITH IMIPRAMINE OR CLOMIPRAMINEMOLLER SE; REISBY N; ORTMANN J et al.1981; J. AFFECTIVE DISORD.; ISSN 0165-0327; NLD; DA. 1981; VOL. 3; NO 3; PP. 231-244; BIBL. 3 P.Article

PLASMA LEVELS AND ANTIDEPRESSIVE EFFECT OF IMIPRAMINEGRAM LF; REISBY N; IBSEN I et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 3; PP. 318-324; BIBL. 18 REF.Article

Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressantsBECH, P; ALLERUP, P; REISBY, N et al.Psychopharmacologia. 1984, Vol 84, Num 2, pp 276-281, issn 0033-3158Article

IMIPRAMINE: CLINICAL EFFECTS AND PHARMACOKINETIC VARIABILITY.REISBY N; GRAM LF; BECH P et al.1977; PSYCHOPHARMACOLOGY; GERM.; DA. 1977; VOL. 54; NO 3; PP. 263-272; BIBL. 28 REF.Article

STEADY-STATE KINETICS OF IMIPRAMINE IN PATIENTS.GRAM LF; SONDERGAARD I; CHRISTIANSEN J et al.1977; PSYCHOPHARMACOLOGY; GERM.; DA. 1977; VOL. 54; NO 3; PP. 255-261; BIBL. 24 REF.Article

Biochemical and diagnostic classification and serum drug levels: relation to antidepressive effect of imipramineMOLLER, S. E; REISBY, N; ELLEY, J et al.Neuropsychobiology. 1985, Vol 13, Num 4, pp 160-166, issn 0302-282XArticle